Bandingkan Harga & Kinerja Selaras Citra Nusantara Perkasa Tbk. (SCNP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Selaras Citra Nusantara Perkasa Tbk. dan Organon Pharma Indonesia Tbk.: Selaras Citra Nusantara Perkasa Tbk. diperdagangkan di Rp153 (kapitalisasi pasar 387,5 M, volume 24 jam 4,65 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Selaras Citra Nusantara Perkasa Tbk. jauh lebih besar — sekitar 3,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCNP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 387,5 M | 104,4 M |
Volume | 4,65 jt | — |
Lot | 46,54 rb | — |
Perputaran | 754,13 jt | — |
Harga Rata-rata | 162,04 | — |
Nilai Transaksi | 754,13 jt | — |
Harga Ekuilibrium Indikatif | 153 | — |
Volume Ekuilibrium Indikatif | 9 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Selaras Citra Nusantara Perkasa Tbk.
PT Selaras Citra Nusantara Perkasa (the Company),located in Bogor, was established based on Notarial Deed of Sukawaty Sumadi, SH. No. 12 dated 24 January 2000. The Company’s commercial operations started in 2000.
Selengkapnya di halaman SCNP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
